CIK 0001714899 · Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463872213
- Phone
- (650) 866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $363,678
- in 3 filings, $327K under 10b5-1 plans
Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-03 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Stock Option (right to buy) | +19,226 | 19,226 | ||
| 2026-06-03 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Option (right to buy) | +19,226 | 19,226 | ||
| 2026-06-03 | FLATLEY JAY T Director | Grant or award | +6,408 | 22,628 | ||
| 2026-06-03 | FLATLEY JAY T Director | Grant or award · Stock Option (right to buy) | +19,226 | 19,226 | ||
| 2026-01-06 | Schuth Alexander O. COFO and Secretary | Sale | −17,218 | $16.50 | $284K | 282,828 |
| 2026-01-06 | Watts Ryan J. President and CEO | Sale | −35,198 | $16.50 | $581K | 296,833 |
| 2026-01-03 | Schuth Alexander O. COFO and Secretary | Grant or award | +57,700 | 300,046 | ||
| 2026-01-03 | Schuth Alexander O. COFO and Secretary | Grant or award · Stock Option (right to buy) | +173,100 | 173,100 | ||
| 2026-01-03 | Watts Ryan J. President and CEO | Grant or award | +78,960 | 332,031 | ||
| 2026-01-03 | Watts Ryan J. President and CEO | Grant or award · Stock Option (right to buy) | +236,880 | 236,880 | ||
| 2025-12-11 | BAKER BROS. ADVISORS LP Director | Purchase · $0.01 Prefunded Warrants | +190,523 | $17.49 | $3.3M | 2,335,469 |
| 2025-12-11 | BAKER BROS. ADVISORS LP Director | Purchase · $0.01 Prefunded Warrants | +2,095,191 | $17.49 | $36.6M | 25,996,310 |
| 2025-11-04 | Van Hauwermeiren Timothy Director | Grant or award | +10,632 | 10,632 | ||
| 2025-11-04 | Van Hauwermeiren Timothy Director | Grant or award · Stock Option (right to buy) | +31,897 | 31,897 | ||
| 2025-09-03 | Watts Ryan J. President and CEO | Gift | −50,000 | 2,152,604 | ||
| 2025-08-13 | Ho Carole Chief Medical Officer | Sale 10b5-1 | −806 | $14.64 | $12K | 216,585 |
| 2025-08-12 | Schuth Alexander O. COFO and Secretary | Sale | −2,937 | $13.58 | $40K | 242,346 |
| 2025-08-12 | Ho Carole Chief Medical Officer | Sale 10b5-1 | −2,937 | $13.58 | $40K | 217,391 |
| 2025-08-05 | Ho Carole Chief Medical Officer | Option exercise | +44,655 | $0.68 | $30K | 220,328 |
| 2025-08-05 | Ho Carole Chief Medical Officer | Option exercise · Stock Option (right to buy) | −44,655 | 62,500 |
Page 2 of 53 · 1,043 trades